Sunstone increases share in Swedish biotech company

The Swedish biotech company Cantagia issues new shares for SEK 232 million (USD 27.71 million) and the major investor Sunstone Capital takes the opportunity to increase its investments in the company that aims for going public on Nasdaq Stockholm in 2018.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us free for 14 days

Try a trial subscription for free access to our quality journalism

Frontpage right now

Latest Top picks in English

Related articles